Home High Flow Oxygen to Reduce Acute Exacerbation of COPD

NARecruitingINTERVENTIONAL
Enrollment

406

Participants

Timeline

Start Date

August 26, 2022

Primary Completion Date

August 26, 2026

Study Completion Date

August 26, 2026

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
OTHER

High Flow Oxygen Therapy

"HFOT will be delivered validated medical devices and established as follow:~* Patient will be acclimatized to HFOT which will aim to achieve a flow of air of 30L/min at a temperature of 34°C using dedicated nasal canula.~* Once patient acclimatized, oxygen will be entrained in the HFOT device at a flow that will aim to achieve a saturation \> 90%. An arterial blood gas will be performed with such oxygen delivery, flowrate and temperature to ensure a PaO2 ≥ 8kPa"

OTHER

Long-term oxygen therapy

LTOT delivery will be performed according to French guidelines

Trial Locations (1)

Unknown

RECRUITING

UHRouen, Rouen

All Listed Sponsors
lead

University Hospital, Rouen

OTHER